These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46 related articles for article (PubMed ID: 8405317)
1. Introduction of Two-Dose Mumps-Containing Vaccine into Routine Immunization Schedule in Quzhou, China, Using Cox-Proportional Hazard Model. Yin Z; Zheng C; Fang Q; Gong X; Cao G; Li J; Xiang Z; Song W J Immunol Res; 2021; 2021():5990417. PubMed ID: 34778466 [TBL] [Abstract][Full Text] [Related]
2. Mumps Outbreaks in Vaccinated Populations-Is It Time to Re-assess the Clinical Efficacy of Vaccines? Connell AR; Connell J; Leahy TR; Hassan J Front Immunol; 2020; 11():2089. PubMed ID: 33072071 [TBL] [Abstract][Full Text] [Related]
4. Two doses of MMR vaccine--sufficient to eradicate measles, mumps and rubella? Fahlgren K Scand J Soc Med; 1988; 16(3):129-35. PubMed ID: 3057621 [TBL] [Abstract][Full Text] [Related]
5. Adult immunization. Korn JE; Poland GA Prim Care; 1989 Mar; 16(1):177-96. PubMed ID: 2649901 [TBL] [Abstract][Full Text] [Related]
6. Duration of the immune response to MMR vaccine in children of two age-different groups. Li Volti S; Giammanco-Bilancia G; Grassi M; Garozzo R; Gluck R; Giammanco G Eur J Epidemiol; 1993 May; 9(3):311-4. PubMed ID: 8405317 [TBL] [Abstract][Full Text] [Related]
7. Immune response to simultaneous administration of a combined measles, mumps and rubella vaccine with booster doses of diphtheria-tetanus and poliovirus vaccine. Giammanco G; Li Volti S; Salemi I; Giammanco Bilancia G; Mauro L Eur J Epidemiol; 1993 Mar; 9(2):199-202. PubMed ID: 8519358 [TBL] [Abstract][Full Text] [Related]
8. Simultaneous administration of a diphtheria and tetanus toxoids and acellular pertussis vaccine with measles-mumps-rubella and oral poliovirus vaccines. Rothstein EP; Bernstein HH; Glode MP; Laussucq S; Nonenmacher J; Long SS; Hackell JG Am J Dis Child; 1993 Aug; 147(8):854-7. PubMed ID: 8394646 [TBL] [Abstract][Full Text] [Related]
9. Simultaneous administration of measles-mumps-rubella vaccine with booster doses of diphtheria-tetanus-pertussis and poliovirus vaccines. Deforest A; Long SS; Lischner HW; Girone JA; Clark JL; Srinivasan R; Maguire TG; Diamond SA; Schiller RP; Rothstein EP Pediatrics; 1988 Feb; 81(2):237-46. PubMed ID: 3340474 [TBL] [Abstract][Full Text] [Related]
10. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants. Dashefsky B; Wald E; Guerra N; Byers C Pediatrics; 1990 Apr; 85(4 Pt 2):682-9. PubMed ID: 2107519 [TBL] [Abstract][Full Text] [Related]
11. New recommended schedule for active immunization of normal infants and children. Centers for Disease Control (CDC) MMWR Morb Mortal Wkly Rep; 1986 Sep; 35(37):577-9. PubMed ID: 3092014 [TBL] [Abstract][Full Text] [Related]
12. Methodologic issues in the evaluation of vaccine effectiveness: measles vaccine at 12 vs. 15 months. Marks JS; Hayden GF; Orenstein WA Am J Epidemiol; 1982 Sep; 116(3):510-23. PubMed ID: 6751071 [TBL] [Abstract][Full Text] [Related]
13. Scandinavian model for eliminating measles, mumps, and rubella. Rabo E; Taranger J Br Med J (Clin Res Ed); 1984 Nov; 289(6456):1402-4. PubMed ID: 6437574 [No Abstract] [Full Text] [Related]
14. Persistence of rubella antibody 8-18 years after vaccination. O'Shea S; Best JM; Banatvala JE; Marshall WC; Dudgeon JA Br Med J (Clin Res Ed); 1984 Apr; 288(6423):1043. PubMed ID: 6423188 [No Abstract] [Full Text] [Related]